SHL Stock Overview
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 3/6 |
Past Performance | 2/6 |
Financial Health | 2/6 |
Dividends | 3/6 |
Siemens Healthineers AG Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €56.86 |
52 Week High | €56.86 |
52 Week Low | €44.94 |
Beta | 0.73 |
1 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | -0.61% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -15.73% |
Recent News & Updates
Recent updates
Shareholder Returns
SHL | BG Medical Equipment | BG Market | |
---|---|---|---|
7D | 0% | -1.3% | 0.6% |
1Y | -0.6% | -0.5% | 17.1% |
Return vs Industry: SHL underperformed the BG Medical Equipment industry which returned 1% over the past year.
Return vs Market: SHL underperformed the BG Market which returned 17.2% over the past year.
Price Volatility
SHL volatility | |
---|---|
SHL Average Weekly Movement | n/a |
Medical Equipment Industry Average Movement | 5.9% |
Market Average Movement | 3.7% |
10% most volatile stocks in BG Market | 8.2% |
10% least volatile stocks in BG Market | 2.4% |
Stable Share Price: SHL has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine SHL's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | 71,400 | Bernd Montag | www.siemens-healthineers.com |
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems.
Siemens Healthineers AG Fundamentals Summary
SHL fundamental statistics | |
---|---|
Market cap | €58.13b |
Earnings (TTM) | €1.52b |
Revenue (TTM) | €21.78b |
38.3x
P/E Ratio2.7x
P/S RatioIs SHL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
SHL income statement (TTM) | |
---|---|
Revenue | €21.78b |
Cost of Revenue | €13.96b |
Gross Profit | €7.82b |
Other Expenses | €6.30b |
Earnings | €1.52b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 07, 2024
Earnings per share (EPS) | 1.36 |
Gross Margin | 35.89% |
Net Profit Margin | 6.97% |
Debt/Equity Ratio | 89.4% |
How did SHL perform over the long term?
See historical performance and comparison